1. Home
  2. GALT vs NCSM Comparison

GALT vs NCSM Comparison

Compare GALT & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

N/A

Current Price

$3.16

Market Cap

176.7M

Sector

Health Care

ML Signal

N/A

Logo NCS Multistage Holdings Inc.

NCSM

NCS Multistage Holdings Inc.

N/A

Current Price

$64.68

Market Cap

170.3M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
GALT
NCSM
Founded
2000
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oilfield Services/Equipment
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
176.7M
170.3M
IPO Year
2008
2017

Fundamental Metrics

Financial Performance
Metric
GALT
NCSM
Price
$3.16
$64.68
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
281.7K
13.8K
Earning Date
01-01-0001
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
239.22
EPS
N/A
8.65
Revenue
N/A
$142,471,000.00
Revenue This Year
N/A
$6.13
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.75
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$25.20
52 Week High
$7.13
$68.40

Technical Indicators

Market Signals
Indicator
GALT
NCSM
Relative Strength Index (RSI) 50.65 84.28
Support Level $2.88 $36.05
Resistance Level $3.27 N/A
Average True Range (ATR) 0.24 2.90
MACD 0.03 2.98
Stochastic Oscillator 44.27 89.58

Price Performance

Historical Comparison
GALT
NCSM

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.

Share on Social Networks: